.
Science Daily : Hormone Disorders
Hormone Disorders News -- ScienceDaily
Read the latest research on endocrinology. Learn about hormone disorders, new hormone treatment options, hormone therapy and more.

Hormone Disorders News -- ScienceDaily
  • Fracking chemicals exposure may harm fertility in female mice
    Prenatal exposure to chemicals used in hydraulic fracturing, or fracking, may threaten fertility in female mice, according to a new study.

  • Melatonin boost a key to fighting breast cancer
    Melatonin, a hormone produced in the human brain, appears to suppress the growth of breast cancer tumors. While treatments based on this new, key discovery are still years away, the results give scientists a key foundation on which to build future research.

  • Steroid treatments with fewer side effects?
    An improved therapy to replace essential steroids in the body is a step closer thanks to new research. The treatment could help people unable to produce a class of steroids called corticosteroids, which are involved in physiological processes including regulating metabolism and blood pressure, and helping the body to cope with physical stress. The therapy for people with adrenal gland disorders is expected to have fewer side effects than existing treatments.

  • New study shows breast tumors evolve in response to hormone therapy
    A new analysis of breast tumors, before and after hormone-reduction therapy, reveals the extreme genetic complexity of these tumors and the variety of responses that are possible to estrogen-deprivation treatments. The findings also suggest that analyzing a single sample of the breast tumor is insufficient for understanding how a patient should best be treated.

  • Soy may help protect women with PCOS from diabetes, heart disease
    Women who have polycystic ovary syndrome -- a common cause of female infertility -- may be able to improve their metabolic and cardiovascular health by consuming soy isoflavones, according to a new study.

The Canary Club is an educational advisory group with a team of medical advisors headed by Richard Shames, M.D.